When de-extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils, we argued that, despite the controversy surrounding the project, the company was building valuable technologies that justify its $10.2 billion valuation. Now, roughly 16 months later, the startup is in talks to raise new funding at a …
Category:
Tech & AI
-
An AWS software bug showed some customers billing estimates in the billions …
-
It’s the First Quarter phase of the lunar cycle tonight, which means …
-
In the middle of a diarrhea shitstorm, the Food and Drug Administration …
-
Anthropic can finally start cutting checks to a group of authors and …
-
San Francisco gave Apple and Google 28 days to address 13 alleged …
-
You’ve waited long enough for Apple’s relaunch of Siri as an AI …
-
“Cards are basically a commodity at the end of the day; how …
-
Chris Fall, the director of the Center for AI Standards and Innovation …
-
Samsung’s US headquarters move to Texas is affecting 739 New Jersey positions …
